New drug trial targets debilitating itch in liver disease patients
NCT ID NCT06733519
Summary
This study is testing whether an investigational drug called TH104 can safely reduce severe itching in people with primary biliary cholangitis (PBC), a chronic liver disease. Forty participants with moderate to severe itching will receive either TH104 or a placebo for six weeks, followed by two weeks of monitoring. The main goal is to check the drug's safety while also measuring its effect on itch intensity and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.